• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

Sigma受体拮抗剂在治疗成瘾性药物滥用致神经毒性中的研究进展

张媛, 孙佳锐, 刘玉秋, 巢杰, 姚红红

张媛, 孙佳锐, 刘玉秋, 巢杰, 姚红红. Sigma受体拮抗剂在治疗成瘾性药物滥用致神经毒性中的研究进展[J]. 中国药科大学学报, 2014, 45(3): 253-258. DOI: 10.11665/j.issn.1000-5048.20140301
引用本文: 张媛, 孙佳锐, 刘玉秋, 巢杰, 姚红红. Sigma受体拮抗剂在治疗成瘾性药物滥用致神经毒性中的研究进展[J]. 中国药科大学学报, 2014, 45(3): 253-258. DOI: 10.11665/j.issn.1000-5048.20140301
shu
ZHANG Yuan, SUN Jiarui, LIU Yuqiu, CHAO Jie, YAO Honghong. Research progress of Sigma receptor antagoinsts in the drug abuse-mediated neurotoxicity[J]. Journal of China Pharmaceutical University, 2014, 45(3): 253-258. DOI: 10.11665/j.issn.1000-5048.20140301
Citation: ZHANG Yuan, SUN Jiarui, LIU Yuqiu, CHAO Jie, YAO Honghong. Research progress of Sigma receptor antagoinsts in the drug abuse-mediated neurotoxicity[J]. Journal of China Pharmaceutical University, 2014, 45(3): 253-258. DOI: 10.11665/j.issn.1000-5048.20140301
shu

Sigma受体拮抗剂在治疗成瘾性药物滥用致神经毒性中的研究进展

  • 东南大学医学院药理学系

基金项目: 国家自然科学基金资助项目(No.81322048)

Research progress of Sigma receptor antagoinsts in the drug abuse-mediated neurotoxicity

摘要

    摘要
  • 摘要: 成瘾性药物滥用是全球普遍存在的社会问题，已成为许多国家仅次于心脑血管疾病和恶性肿瘤的第3位致死病因，在我国形势也日趋严峻。脑内奖赏系统单胺学说是早期认识成瘾性药物滥用的里程碑理论，但这一学说无法解释成瘾性药物滥用者脑内由不同细胞间相互作用而引起的神经炎性级联反应最终导致的神经毒性。如何遏制成瘾性药物滥用过程中的神经炎性反应，降低神经毒性反应，是亟待解决的课题。目前，国外有关这方面的研究还处于起步阶段，仅限于大量临床病例报道；国内研究尚属空白，其确切的分子机制值得深入挖掘。本文主要针对Sigma受体拮抗剂在治疗成瘾性药物滥用导致的神经毒性中的研究进行综述，为成瘾性药物滥用致神经毒性作用提供新的药物靶标和新的治疗策略。
    Abstract: Drug abuse represents a serious health issue worldwide resulting personal suffering, as well as social and economic burden. Drug abuse is considered the third killer in some western societies since it affects more and more people, compared with cerebral-cardiovascular disease or malignant cancer. China faces emerging epidemics of drug abuse as evidenced that drug abusers are on the rise in recent years. Despite the recognized impact of drug abuse on the brain reward system, mechanisms underlying the ability of drug abuse to initiate a cascade of neuroinflammatory response, which finally result in widespread neurotoxicity within the complex network of cell-to-cell interactions, have not yet been fully identified. Understanding the detailed mechanisms underlying neuropathological progression induced by drug abuse is thus the next logical step that is of paramount importance. The control and eradication of neurological complications associated with drug abuse continues to be an important goal toward improving the well-being of drug abusers. This review summarizes the potential role of Sigma receptor antagoinsts in drug abuse-mediated neuroinflammation and neurotoxicity, both of which comprise the hallmark features of drug abusers. These findings will set a stage for providing a new generation of novel therapeutic agents for drug abuse involving neuroinflammation and neurotoxicity.
    • HTML全文
    • 参考文献(45)
  • [1] Schmitt KC,Reith ME.Regulation of the dopamine transporter:aspects relevant to psychostimulant drugs of abuse[J].Ann N Y Acad Sci,2010,1 187:316-340.
    [2] Iversen L.Neurotransmitter transporters and their impact on the development of psychopharmacology[J].Br J Pharmacol,2006,147(Suppl 1):S82-88.
    [3] Yao H,Yang Y,Kim KJ,et al.Molecular mechanisms involving sigma receptor-mediated induction of MCP-1:implication for increased monocyte transmigration[J].Blood,2010,115(23):4 951-4 962.
    [4] Little KY,Ramssen E,Welchko R,et al.Decreased brain dopamine cell numbers in human cocaine users[J].Psychiatry Res,2009,168(3):173-180.
    [5] Buttner A.Review:the neuropathology of drug abuse[J].Neuropathol Appl Neurobiol,2011,37(2):118-134.
    [6] Martin WR,Eades CG,Thompson JA,et al.The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog[J].J Pharmacol Exp Ther,1976,197(3):517-532.
    [7] Su TP,London ED,Jaffe JH.Steroid binding at sigma receptors suggests a link between endocrine,nervous,and immune systems[J].Science,1988,240(4 849):219-221.
    [8] Kourrich S,Su TP,Fujimoto M,et al.The sigma-1 receptor:roles in neuronal plasticity and disease[J].Trends Neurosci,2012,35(12):762-771.
    [9] Nuwayhid SJ,Werling LL.Sigma1 receptor agonist-mediated regulation of N-methyl-D-aspartate-stimulated[3H]dopamine release is dependent upon protein kinase C[J].J Pharmacol Exp Ther,2003,304(1):364-369.
    [10] Matsumoto RR,Liu Y,Lerner M,et al.Sigma receptors:potential medications development target for anti-cocaine agents[J].Eur J Pharmacol,2003,469(1/2/3):1-12.
    [11] Hayashi T,Su TP.Regulating ankyrin dynamics:Roles of sigma-1 receptors[J].Proc Natl Acad Sci U S A,2001,98(2):491-496.
    [12] Su TP,Shukla K,Gund T.Steroid binding at sigma receptors:CNS and immunological implications[J].Ciba Found Symp,1990,153:107-113;discussion 113-106.
    [13] Hashimoto K,Ishiwata K.Sigma receptor ligands:possible application as therapeutic drugs and as radiopharmaceuticals[J].Curr Pharm Des,2006,12(30):3 857-3 876.
    [14] Huang YS,Lu HL,Zhang LJ,et al.Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy[J].Med Res Rev,2014,34(3):532-566.
    [15] Cobos EJ,Entrena JM,Nieto FR,et al.Pharmacology and therapeutic potential of sigma(1)receptor ligands[J].Curr Neuropharmacol,2008,6(4):344-366.
    [16] Narayanan S,Mesangeau C,Poupaert JH,et al.Sigma receptors and cocaine abuse[J].Curr Top Med Chem,2011,11(9):1 128-1 150.
    [17] Rodvelt KR,Miller DK.Could sigma receptor ligands be a treatment for methamphetamine addiction[J]?Curr Drug Abuse Rev,2010,3(3):156-162.
    [18] Matsumoto RR. Targeting sigma receptors: novel medication development for drug abuse and addiction[J].Expert Rev Clin Pharmacol,2009,2(4):351-358.
    [19] Xu YT,Robson MJ,Szeszel-Fedorowicz W,et al.CM156,a sigma receptor ligand,reverses cocaine-induced place conditioning and transcriptional responses in the brain[J].Pharmacol Biochem Behav,2012,101(1):174-180.
    [20] Robson MJ,Turner RC,Naser ZJ,et al.SN79,a sigma receptor ligand,blocks methamphetamine-induced microglial activation and cytokine upregulation[J].Exp Neurol,2013,247:134-142.
    [21] Kaushal N,Matsumoto RR.Role of sigma receptors in methamphetamine-induced neurotoxicity[J].Curr Neuropharmacol,2011,9(1):54-57.
    [22] Sharkey J,Glen KA,Wolfe S,et al.Cocaine binding at sigma receptors[J].Eur J Pharmacol,1988,149(1/2):171-174.
    [23] Gan X,Zhang L,Berger O,et al.Cocaine enhances brain endothelial adhesion molecules and leukocyte migration[J].Clin Immunol,1999,91(1):68-76.
    [24] Yao H,Duan M,Hu G,et al.Platelet-derived growth factor B chain is a novel target gene of cocaine-mediated Notch1 signaling:implications for HIV-associated neurological disorders[J].J Neurosci,2011,31(35):12 449-12 454.
    [25] Yao H,Kim K,Duan M,et al.Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule:implication for increased monocyte adhesion and migration in the CNS[J].J Neurosci,2011,31(16):5 942-5 955.
    [26] Hall AA,Herrera Y,Ajmo CT Jr,et al.Sigma receptors suppress multiple aspects of microglial activation[J].Glia,2009,57(7):744-754.
    [27] Cuevas J,Rodriguez A,Behensky A,et al.Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors[J].J Pharmacol Exp Ther,2011,339(1):161-172.
    [28] Gekker G, Hu S, Sheng WS, et al. Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1[J].Int Immunopharmacol,2006,6(6):1 029-1 033.
    [29] Roth MD,Tashkin DP,Choi R,et al.Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes[J].J Infect Dis,2002,185(5):701-705.
    [30] Roth MD, Whittaker KM, Choi R, et al. Cocaine and sigma-1 receptors modulate HIV infection,chemokine receptors,and the HPA axis in the huPBL-SCID model[J].J Leukoc Biol,2005,78(6):1 198-1 203.
    [31] Ben-Ami O, Kinor N, Perelman A, et al. Dopamine-1 receptor agonist,but not cocaine,modulates sigma(1)gene expression in SVG cells[J].J Mol Neurosci,2006,29(2):169-176.
    [32] Krasnova IN,Cadet JL.Methamphetamine toxicity and messengers of death[J].Brain Res Rev,2009,60(2):379-407.
    [33] Nguyen EC,McCracken KA,Liu Y,et al.Involvement of sigma(sigma)receptors in the acute actions of methamphetamine:receptor binding and behavioral studies[J].Neuropharmacology,2005,49(5):638-645.
    [34] Kaushal N,Seminerio MJ,Shaikh J,et al.CM156,a high affinity sigma ligand,attenuates the stimulant and neurotoxic effects of methamphetamine in mice[J].Neuropharmacology,2011,61(5/6):992-1 000.
    [35] Matsumoto RR,Shaikh J,Wilson LL,et al.Attenuation of methamphetamine-induced effects through the antagonism of sigma(sigma)receptors:evidence from in vivo and in vitro studies[J].Eur Neuropsychopharmacol,2008,18(12):871-881.
    [36] Smith KJ, Butler TR, Prendergast MA. Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi[J].Neurosci Lett,2010,481(3):144-148.
    [37] Seminerio MJ,Hansen R,Kaushal N,et al.The evaluation of AZ66,an optimized sigma receptor antagonist,against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice[J].Int J Neuropsychopharmacol,2013,16(5):1 033-1 044.
    [38] Robson MJ,Seminerio MJ,McCurdy CR,et al.sigma Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation[J].Pharmacol Rep,2013,65(2):343-349.
    [39] Northrop NA,Yamamoto BK.Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier[J].J Neuroimmune Pharmacol,2012,7(4):951-968.
    [40] Bowyer JF,Thomas M,Schmued LC,et al.Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose,hyperthermia,seizures,and the blood-brain barrier[J].Ann N Y Acad Sci,2008,1 139:127-139.
    [41] Martins T,Baptista S,Goncalves J,et al.Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus:role of tight junction proteins and matrix metalloproteinase-9[J].Brain Res,2011,1 411:28-40.
    [42] Bowyer JF,Robinson B,Ali S,et al.Neurotoxic-related changes in tyrosine hydroxylase,microglia,myelin,and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure[J].Synapse,2008,62(3):193-204.
    [43] Bowyer JF,Ali S.High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus[J].Synapse,2006,60(7):521-532.
    [44] Chen SL,Hsu KY,Huang EY,et al.Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats[J].Drug Alcohol Depend,2011,117(2/3):164-169.
    [45] Sabino V,Cottone P,Zhao Y,et al.The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking[J].Neuropsychopharmacology,2009,34(6):1 482-1 493.
    • 相关文章
    • 施引文献
    • 资源附件(0)
计量
  • 文章访问数:  1417
  • HTML全文浏览量:  0
  • PDF下载量:  2591
  • 被引次数: 0
出版历程
  • 刊出日期:  2014-06-24

目录

摘要
HTML全文
    参考文献(45)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    版权所有：《中国药科大学学报》编辑部苏ICP备05007142号

    地址：江苏省南京市鼓楼区童家巷24号（210009）电话: 025-83271566E-mail: xuebao@cpu.edu.cn

    本系统由 北京仁和汇智信息技术有限公司 开发  百度统计

    访问量：323975

    x 关闭 永久关闭